DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management
…
continue reading
Defination Uses Various processes in Tissue - culture
…
continue reading
Welcome to the Biotech Bytes podcast, where we sit down with Biotech and Pharma IT leaders to learn what's working in our industry. Steven Swan is the CEO of The Swan Group LLC. He has 20 years of experience working with companies and individuals to make long-term matches. Focusing on Information technology within the Biotech and Pharmaceutical industries has allowed The Swan Group to become a valued partner to many companies. Staying in constant contact with the marketplace and its trends a ...
…
continue reading
Biotechnology for Tomorrow
…
continue reading
What happens when robots, AI, and big data enter the hospital? Glenn Cohen (a professor and deputy dean at Harvard Law School) is unpacking that question in this exploration of biotechnology, ethics, medical law, and health care policy. Each week, he’ll interrogate a single technology – such as digital pills, AI-powered decision support algorithms, or digital health apps – through the lens of ethical concerns like informed consent, liability, and privacy.
…
continue reading
Chiral switching, the practice of developing a single enantiomer from a previously approved racemic drug, has been a significant strategy […]SourceDrugPatentWatch
…
continue reading
The rapid advancements in biotechnology are transforming the industry. Emerging technologies hold the promise of revolutionizing healthcare and enhancing our quality of life. In this episode, I sit down with Steven Bressler, a fractional CIO from Strategic Technology Management, Inc., to discuss the latest trends in biotechnology. We explore the po…
…
continue reading
Developing a competitive edge in generic drug development is crucial for companies to gain a significant market share and dominate […]SourceDrugPatentWatch
…
continue reading
To identify Key Starting Materials (KSMs) for Active Pharmaceutical Ingredients (APIs), pharmaceutical companies and regulatory bodies follow a systematic approach […]SourceDrugPatentWatch
…
continue reading
The generic drug market has been significantly impacted by the COVID-19 pandemic, with both challenges and opportunities arising from the […]SourceDrugPatentWatch
…
continue reading
In the high-stakes world of pharmaceuticals, generic drugs have become the unsung heroes of healthcare accessibility. These cost-effective alternatives to […]SourceDrugPatentWatch
…
continue reading
In the high-stakes world of pharmaceutical innovation, drafting detailed drug patent claims is a critical process that can make or […]SourceDrugPatentWatch
…
continue reading
As patents expire on blockbuster biologic drugs, manufacturers are increasingly employing a controversial tactic known as “product hopping” to maintain […]SourceDrugPatentWatch
…
continue reading
Enantiomer Switching: A Pharmaceutical Strategy to Extend Drug Patents Enantiomer switching, also known as chiral switching, is a strategy employed […]SourceDrugPatentWatch
…
continue reading
In the rapidly evolving landscape of biosimilars, intellectual property (IP) strategy is paramount. Biosimilar manufacturers face unique challenges, including navigating […]SourceDrugPatentWatch
…
continue reading
Introduction The Patent Trial and Appeal Board (PTAB) is a crucial component of the United States Patent and Trademark Office […]SourceDrugPatentWatch
…
continue reading
Transitioning to a new Contract Development and Manufacturing Organization (CDMO) can be a complex and challenging process. However, by following […]SourceDrugPatentWatch
…
continue reading
The High Stakes of Pharmaceutical Patent Litigation In the fiercely competitive pharmaceutical industry, patent disputes can make or break a […]SourceDrugPatentWatch
…
continue reading
Introduction Patent oppositions are a crucial tool in the pharmaceutical industry, allowing civil society to challenge the validity of patents […]SourceDrugPatentWatch
…
continue reading
The Strategic Advantage of Complex Drug Delivery Systems In the highly competitive pharmaceutical landscape, adopting complex drug delivery systems can […]SourceDrugPatentWatch
…
continue reading
An HHS report titled “The Potential Role of The Nonprofit Pharmaceutical Industry in Addressing Shortages and Increasing Access to Essential […]SourceDrugPatentWatch
…
continue reading
The value proposition of Contract Development and Manufacturing Organizations (CDMOs) has become increasingly crucial in the pharmaceutical industry. As the […]SourceDrugPatentWatch
…
continue reading
In the high-stakes world of biosimilar development, manufacturers are increasingly turning to an unexpected partner: the Patent Trial and Appeal […]SourceDrugPatentWatch
…
continue reading
As companies evolve, the structuring and management of data become critical for scalability and efficiency. Failure to prioritize this can hinder the adoption of advanced technologies like machine learning. Nathan McBride, Senior Vice President of IT at Xilio Therapeutics, Inc., joins me today to explore the intricacies of effective data structurin…
…
continue reading
This is an example from the DrugPatentWatch AI Research Assistant, which is available with DrugPatentWatch subscriptions. The DrugPatentWatch AI Research […]SourceDrugPatentWatch
…
continue reading
The introduction of biosimilars has significantly altered the landscape of biologic drug distribution models. Biosimilars, which are highly similar to […]SourceDrugPatentWatch
…
continue reading
In a seismic shift for European intellectual property, the Unified Patent Court (UPC) is rapidly transforming how businesses approach patent […]SourceDrugPatentWatch
…
continue reading
To find low-competition generic drug opportunities, focus on drugs with limited competition due to small patient populations, complex formulations, or […]SourceDrugPatentWatch
…
continue reading
The integration of artificial intelligence (AI) into drug discovery and development is revolutionizing the pharmaceutical industry. AI’s ability to analyze […]SourceDrugPatentWatch
…
continue reading
China is emerging as a global frontrunner in patenting artificial intelligence (AI) technologies for drug discovery, particularly in the field […]SourceDrugPatentWatch
…
continue reading
The pharmaceutical industry is a high-stakes arena where innovation, investment, and intellectual property (IP) protection intersect. One of the most […]SourceDrugPatentWatch
…
continue reading
Lipitor’s marketing strategy underwent a significant evolution as generic competition emerged, employing aggressive tactics to retain market share and brand […]SourceDrugPatentWatch
…
continue reading
Patent Expirations and Generic Competition This week saw several major blockbuster drugs facing patent expirations, potentially opening the market for […]SourceDrugPatentWatch
…
continue reading
Introduction Patent portfolios are critical assets for pharmaceutical companies, providing market exclusivity and protecting revenue streams for drug products. Effective […]SourceDrugPatentWatch
…
continue reading
This is an example from the DrugPatentWatch AI Research Assistant, which is available with DrugPatentWatch subscriptions. The DrugPatentWatch AI Research […]SourceDrugPatentWatch
…
continue reading
Introduction In the rapidly evolving landscape of pharmaceutical patent disputes in China, injunctive relief has emerged as a critical tool […]SourceDrugPatentWatch
…
continue reading
DrugChatter is an innovative AI-powered search and answer engine designed to revolutionize how we access and comprehend information. Harnessing the […]SourceDrugPatentWatch
…
continue reading
![Artwork](/static/images/128pixel.png)
1
USPTO Study Reveals Trends and Insights into Drug Patent and Exclusivity Trends in the Pharmaceutical Industry
Introduction: The United States Patent and Trademark Office (USPTO) has recently released a comprehensive study on drug patents and exclusivity […]SourceDrugPatentWatch
…
continue reading
The 505(b)(2) regulatory pathway provides an attractive avenue for drug developers to bring new products to market by leveraging existing […]SourceDrugPatentWatch
…
continue reading
In the high-stakes world of pharmaceuticals, patents play a pivotal role in safeguarding intellectual property and ensuring a return on […]SourceDrugPatentWatch
…
continue reading
The quality of leadership and innovation in biotechnology is experiencing a significant transformation. Joining me today is Pasqual Zottola, Vice President of Information Technology at Acorda Therapeutics, Inc. We talk about how integrating advanced technological solutions and standout leadership principles leads to sustainable success in biotech. …
…
continue reading
In the ever-evolving pharmaceutical landscape, savvy businesses are constantly on the lookout for untapped markets and lucrative opportunities. One area […]SourceDrugPatentWatch
…
continue reading
Branded generics are generic drugs that are marketed under a brand name by the manufacturer. These products contain the same […]SourceDrugPatentWatch
…
continue reading
A recent whitepaper by Hermann Mucke summarizes the steps to performing an FTO for drug repurposing: Overview An FtO analysis […]SourceDrugPatentWatch
…
continue reading
The article “The devil is in the divisional: an analysis of divisional patents, deadlines, declarations and suggestions for future practice” […]SourceDrugPatentWatch
…
continue reading
Pharmaceutical companies employ various strategies to extend the commercial life and patent protection of successful drugs. Here are some key […]SourceDrugPatentWatch
…
continue reading
Sure, here’s a more detailed explanation with examples: Drug Patent Duration Drug patents are granted by the United States Patent […]SourceDrugPatentWatch
…
continue reading
In the “Patent Effect” podcast, Mustafa introduces his guest, Hakan Yum, the IP Director of Exrain Pharma, based in Sweden. […]SourceDrugPatentWatch
…
continue reading
In a recent study published in the Expert Review of Medical Devices, researchers investigated the utilization of patent term extensions […]SourceDrugPatentWatch
…
continue reading
We're seeing a revolution in how we protect our data and systems, driven by rapidly evolving threats and the need for more sophisticated defenses. Our guest, Kelly Randis, Head of Global Information Technology at Gamida Cell Ltd., brings over three decades of IT expertise, primarily in the pharmaceutical industry. We discuss how AI is reshaping sec…
…
continue reading
Science isn't just about discovery; it's about doing it right to ensure reliability and validity. Joining me is Jonathon Hill, an epitome of a scientist, educator, innovator, and the Co-founder and Vice President of Science and Technology at Wasatch Biolabs. Although trained initially as a premed, Jonathon's professional journey took a deep dive in…
…
continue reading
The intersection of data and artificial intelligence forms the cornerstone of today's healthcare innovation, transforming the way we approach medical advancements. In this week’s episode, I'm excited to welcome Keshia Maughn from STATinMED, a company carving out its space with a focus on specialized data solutions in biotech. We look at the nuances…
…
continue reading
How do today’s biotech companies cultivate innovation and harness digital tools for strategic growth? In this episode, we dissect the pivotal role that digital enterprise capabilities play in transforming a company's approach to challenges in the life sciences sector. As I chat with Matt Lasmanis, Chief Technology & Innovation Officer at Sage Thera…
…
continue reading
Drug repurposing, or identifying new therapeutic uses for existing drugs, is gaining significant momentum as a promising approach to accelerate […]SourceDrugPatentWatch
…
continue reading
The pharmaceutical industry in China is undergoing a significant transformation with the adoption of artificial intelligence (AI) technology. A recent […]SourceDrugPatentWatch
…
continue reading